{"entity":{"type":"insider","cik":"0001698262","url":"/insider/0001698262","json_url":"/insider/0001698262.json","name":"ROTE WILLIAM E.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":53,"n_filings":37,"first":"2018-02-16","last":"2026-05-06","span_basis":"filed_date"},"name_variants":[{"name":"ROTE WILLIAM E.","source":"filing","n_filings":37,"first_seen":"2018-02-16","last_seen":"2026-05-06"}],"transactions":[{"id":5767244,"accession":"0001698262-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001698262-26-000004","line_url":"/filing/0001698262-26-000004#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2763.0,"shares_display":"2,763","price_per_share":43.95,"price_display":"43.95","price_state":"stated","total_value":121433.85,"total_display":"121,433.85","total_whole":"121,434","shares_owned_after":115474.0,"shares_owned_after_display":"115,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-06","filed_date":"2026-05-06","scope":"insider"},{"id":6175115,"accession":"0001698262-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001698262-26-000003","line_url":"/filing/0001698262-26-000003#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9100.0,"shares_display":"9,100","price_per_share":39.09,"price_display":"39.09","price_state":"stated","total_value":355719.0,"total_display":"355,719.00","total_whole":"355,719","shares_owned_after":113987.0,"shares_owned_after_display":"113,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-22","filed_date":"2026-04-23","scope":"insider"},{"id":5803260,"accession":"0001698262-26-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001698262-26-000001","line_url":"/filing/0001698262-26-000001#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12446.0,"shares_display":"12,446","price_per_share":32.87,"price_display":"32.87","price_state":"stated","total_value":409100.02,"total_display":"409,100.02","total_whole":"409,100","shares_owned_after":109087.0,"shares_owned_after_display":"109,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-03","filed_date":"2026-02-03","scope":"insider"},{"id":4185104,"accession":"0001698262-25-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001698262-25-000005","line_url":"/filing/0001698262-25-000005#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":40.103,"price_display":"40.10","price_state":"stated","total_value":2406180.0,"total_display":"2,406,180.00","total_whole":"2,406,180","shares_owned_after":101443.0,"shares_owned_after_display":"101,443","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-24","filed_date":"2025-12-29","scope":"insider"},{"id":4919819,"accession":"0001415889-25-012056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-012056","line_url":"/filing/0001415889-25-012056#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3198.0,"shares_display":"3,198","price_per_share":21.05,"price_display":"21.05","price_state":"stated","total_value":67317.9,"total_display":"67,317.90","total_whole":"67,318","shares_owned_after":100241.0,"shares_owned_after_display":"100,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-05","filed_date":"2025-05-05","scope":"insider"},{"id":4107951,"accession":"0001415889-25-003824","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-003824","line_url":"/filing/0001415889-25-003824#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (SENIOR VICE PRESIDENT, R&D)","role_mark":"O","role_mark_label":"Officer (SENIOR VICE PRESIDENT, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SENIOR VICE PRESIDENT, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5200.0,"shares_display":"5,200","price_per_share":23.53,"price_display":"23.53","price_state":"stated","total_value":122356.0,"total_display":"122,356.00","total_whole":"122,356","shares_owned_after":98519.0,"shares_owned_after_display":"98,519","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-12","filed_date":"2025-02-12","scope":"insider"},{"id":4640085,"accession":"0001415889-25-003067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-003067","line_url":"/filing/0001415889-25-003067#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (SENIOR VICE PRESIDENT, R&D)","role_mark":"O","role_mark_label":"Officer (SENIOR VICE PRESIDENT, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SENIOR VICE PRESIDENT, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8951.0,"shares_display":"8,951","price_per_share":19.78,"price_display":"19.78","price_state":"stated","total_value":177050.78,"total_display":"177,050.78","total_whole":"177,051","shares_owned_after":95719.0,"shares_owned_after_display":"95,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-04","scope":"insider"},{"id":4074201,"accession":"0001415889-25-002008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-002008","line_url":"/filing/0001415889-25-002008#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (SENIOR VICE PRESIDENT, R&D)","role_mark":"O","role_mark_label":"Officer (SENIOR VICE PRESIDENT, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SENIOR VICE PRESIDENT, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2437.0,"shares_display":"2,437","price_per_share":19.46,"price_display":"19.46","price_state":"stated","total_value":47424.02,"total_display":"47,424.02","total_whole":"47,424","shares_owned_after":83170.0,"shares_owned_after_display":"83,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-22","filed_date":"2025-01-23","scope":"insider"},{"id":2954328,"accession":"0001415889-24-023096","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-023096","line_url":"/filing/0001415889-24-023096#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (SENIOR VICE PRESIDENT, R&D)","role_mark":"O","role_mark_label":"Officer (SENIOR VICE PRESIDENT, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SENIOR VICE PRESIDENT, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4387.0,"shares_display":"4,387","price_per_share":11.52,"price_display":"11.52","price_state":"stated","total_value":50538.24,"total_display":"50,538.24","total_whole":"50,538","shares_owned_after":84455.0,"shares_owned_after_display":"84,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-09","filed_date":"2024-09-09","scope":"insider"},{"id":3175491,"accession":"0001415889-24-002284","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-002284","line_url":"/filing/0001415889-24-002284","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (SENIOR VICE PRESIDENT, R&D)","role_mark":"O","role_mark_label":"Officer (SENIOR VICE PRESIDENT, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SENIOR VICE PRESIDENT, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4764.0,"shares_display":"4,764","price_per_share":8.710138203190596,"price_display":"8.71","price_state":"stated","total_value":41495.0984,"total_display":"41,495.10","total_whole":"41,495","shares_owned_after":80720.0,"shares_owned_after_display":"80,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-02","scope":"insider","n_lines":2},{"id":3251612,"accession":"0001415889-24-001800","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-001800","line_url":"/filing/0001415889-24-001800#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (SENIOR VICE PRESIDENT, R&D)","role_mark":"O","role_mark_label":"Officer (SENIOR VICE PRESIDENT, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SENIOR VICE PRESIDENT, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2062.0,"shares_display":"2,062","price_per_share":8.96,"price_display":"8.96","price_state":"stated","total_value":18475.52,"total_display":"18,475.52","total_whole":"18,476","shares_owned_after":60484.0,"shares_owned_after_display":"60,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-23","filed_date":"2024-01-25","scope":"insider"},{"id":8546851,"accession":"0001209191-23-048257","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-048257","line_url":"/filing/0001209191-23-048257#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1815.0,"shares_display":"1,815","price_per_share":14.71,"price_display":"14.71","price_state":"stated","total_value":26698.65,"total_display":"26,698.65","total_whole":"26,699","shares_owned_after":61173.0,"shares_owned_after_display":"61,173","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-05","filed_date":"2023-09-05","scope":"insider"},{"id":8250590,"accession":"0001209191-23-029000","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-029000","line_url":"/filing/0001209191-23-029000#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":825.0,"shares_display":"825","price_per_share":16.59,"price_display":"16.59","price_state":"stated","total_value":13686.75,"total_display":"13,686.75","total_whole":"13,687","shares_owned_after":59211.0,"shares_owned_after_display":"59,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-10","filed_date":"2023-05-12","scope":"insider"},{"id":8677510,"accession":"0001209191-23-006432","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-006432","line_url":"/filing/0001209191-23-006432#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2590.0,"shares_display":"2,590","price_per_share":22.25,"price_display":"22.25","price_state":"stated","total_value":57627.5,"total_display":"57,627.50","total_whole":"57,628","shares_owned_after":60036.0,"shares_owned_after_display":"60,036","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-02","scope":"insider"},{"id":8182538,"accession":"0001209191-23-005036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-005036","line_url":"/filing/0001209191-23-005036#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2062.0,"shares_display":"2,062","price_per_share":21.5,"price_display":"21.50","price_state":"stated","total_value":44333.0,"total_display":"44,333.00","total_whole":"44,333","shares_owned_after":42376.0,"shares_owned_after_display":"42,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-24","filed_date":"2023-01-26","scope":"insider"},{"id":6351924,"accession":"0001209191-22-028710","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-028710","line_url":"/filing/0001209191-22-028710","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1563.0,"shares_display":"1,563","price_per_share":21.714812476007676,"price_display":"21.71","price_state":"stated","total_value":33940.2519,"total_display":"33,940.25","total_whole":"33,940","shares_owned_after":43672.0,"shares_owned_after_display":"43,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-11","filed_date":"2022-05-12","scope":"insider","n_lines":2},{"id":6918181,"accession":"0001209191-22-006367","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-006367","line_url":"/filing/0001209191-22-006367#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1125.0,"shares_display":"1,125","price_per_share":27.4,"price_display":"27.40","price_state":"stated","total_value":30825.0,"total_display":"30,825.00","total_whole":"30,825","shares_owned_after":45235.0,"shares_owned_after_display":"45,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-31","filed_date":"2022-02-02","scope":"insider"},{"id":6294539,"accession":"0001209191-22-005083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-005083","line_url":"/filing/0001209191-22-005083#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1875.0,"shares_display":"1,875","price_per_share":24.98,"price_display":"24.98","price_state":"stated","total_value":46837.5,"total_display":"46,837.50","total_whole":"46,838","shares_owned_after":36520.0,"shares_owned_after_display":"36,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-24","filed_date":"2022-01-26","scope":"insider"},{"id":6749596,"accession":"0001209191-22-003050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-003050","line_url":"/filing/0001209191-22-003050#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":27.4,"price_display":"27.40","price_state":"stated","total_value":68500.0,"total_display":"68,500.00","total_whole":"68,500","shares_owned_after":38395.0,"shares_owned_after_display":"38,395","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-11","filed_date":"2022-01-12","scope":"insider"},{"id":5381519,"accession":"0001209191-21-052081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-052081","line_url":"/filing/0001209191-21-052081#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1407.0,"shares_display":"1,407","price_per_share":17.1183,"price_display":"17.12","price_state":"stated","total_value":24085.4481,"total_display":"24,085.45","total_whole":"24,085","shares_owned_after":35731.0,"shares_owned_after_display":"35,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-17","scope":"insider"},{"id":4179986,"accession":"0001209191-21-032322","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-032322","line_url":"/filing/0001209191-21-032322#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1562.0,"shares_display":"1,562","price_per_share":19.46,"price_display":"19.46","price_state":"stated","total_value":30396.52,"total_display":"30,396.52","total_whole":"30,397","shares_owned_after":31707.0,"shares_owned_after_display":"31,707","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-13","scope":"insider"},{"id":4179979,"accession":"0001209191-21-032322","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-032322","line_url":"/filing/0001209191-21-032322#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1563.0,"shares_display":"1,563","price_per_share":19.14,"price_display":"19.14","price_state":"stated","total_value":29915.82,"total_display":"29,915.82","total_whole":"29,916","shares_owned_after":33269.0,"shares_owned_after_display":"33,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-13","scope":"insider"},{"id":5321744,"accession":"0001209191-21-012062","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-012062","line_url":"/filing/0001209191-21-012062#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":28.67,"price_display":"28.67","price_state":"stated","total_value":35837.5,"total_display":"35,837.50","total_whole":"35,838","shares_owned_after":34832.0,"shares_owned_after_display":"34,832","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-18","filed_date":"2021-02-18","scope":"insider"},{"id":5321741,"accession":"0001209191-21-012062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-012062","line_url":"/filing/0001209191-21-012062#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":27.35,"price_display":"27.35","price_state":"stated","total_value":34187.5,"total_display":"34,187.50","total_whole":"34,188","shares_owned_after":36082.0,"shares_owned_after_display":"36,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-18","scope":"insider"},{"id":5422625,"accession":"0001209191-21-008810","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-008810","line_url":"/filing/0001209191-21-008810#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2250.0,"shares_display":"2,250","price_per_share":31.58,"price_display":"31.58","price_state":"stated","total_value":71055.0,"total_display":"71,055.00","total_whole":"71,055","shares_owned_after":37332.0,"shares_owned_after_display":"37,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-09","scope":"insider"},{"id":5422618,"accession":"0001209191-21-008810","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-008810","line_url":"/filing/0001209191-21-008810#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2250.0,"shares_display":"2,250","price_per_share":31.41,"price_display":"31.41","price_state":"stated","total_value":70672.5,"total_display":"70,672.50","total_whole":"70,673","shares_owned_after":39582.0,"shares_owned_after_display":"39,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-05","filed_date":"2021-02-09","scope":"insider"},{"id":4176514,"accession":"0001209191-21-007634","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-007634","line_url":"/filing/0001209191-21-007634","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3625.0,"shares_display":"3,625","price_per_share":28.91,"price_display":"28.91","price_state":"stated","total_value":104798.75,"total_display":"104,798.75","total_whole":"104,799","shares_owned_after":38457.0,"shares_owned_after_display":"38,457","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-03","filed_date":"2021-02-03","scope":"insider","n_lines":2},{"id":4772849,"accession":"0001209191-21-007028","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-007028","line_url":"/filing/0001209191-21-007028","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3625.0,"shares_display":"3,625","price_per_share":30.75,"price_display":"30.75","price_state":"stated","total_value":111468.75,"total_display":"111,468.75","total_whole":"111,469","shares_owned_after":40957.0,"shares_owned_after_display":"40,957","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-02","scope":"insider","n_lines":2},{"id":2659128,"accession":"0001209191-20-058943","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-058943","line_url":"/filing/0001209191-20-058943#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":23.96,"price_display":"23.96","price_state":"stated","total_value":59900.0,"total_display":"59,900.00","total_whole":"59,900","shares_owned_after":24086.0,"shares_owned_after_display":"24,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-17","scope":"insider"},{"id":2478766,"accession":"0001209191-20-058418","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-058418","line_url":"/filing/0001209191-20-058418#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":23.6224,"price_display":"23.62","price_state":"stated","total_value":59056.0,"total_display":"59,056.00","total_whole":"59,056","shares_owned_after":26586.0,"shares_owned_after_display":"26,586","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-13","filed_date":"2020-11-13","scope":"insider"},{"id":3260372,"accession":"0001209191-20-051736","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-051736","line_url":"/filing/0001209191-20-051736#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":18.48,"price_display":"18.48","price_state":"stated","total_value":27720.0,"total_display":"27,720.00","total_whole":"27,720","shares_owned_after":24086.0,"shares_owned_after_display":"24,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-23","filed_date":"2020-09-23","scope":"insider"},{"id":2657802,"accession":"0001209191-20-051615","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-051615","line_url":"/filing/0001209191-20-051615#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":18.59,"price_display":"18.59","price_state":"stated","total_value":27885.0,"total_display":"27,885.00","total_whole":"27,885","shares_owned_after":25586.0,"shares_owned_after_display":"25,586","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-22","filed_date":"2020-09-22","scope":"insider"},{"id":2469168,"accession":"0001209191-20-029023","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-029023","line_url":"/filing/0001209191-20-029023","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1339.0,"shares_display":"1,339","price_per_share":17.090848469006723,"price_display":"17.09","price_state":"stated","total_value":22884.6461,"total_display":"22,884.65","total_whole":"22,885","shares_owned_after":24021.0,"shares_owned_after_display":"24,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2020-05-13","scope":"insider","n_lines":2},{"id":2469156,"accession":"0001209191-20-029023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-029023","line_url":"/filing/0001209191-20-029023#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":813.0,"shares_display":"813","price_per_share":14.95,"price_display":"14.95","price_state":"stated","total_value":12154.35,"total_display":"12,154.35","total_whole":"12,154","shares_owned_after":24833.0,"shares_owned_after_display":"24,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-11","filed_date":"2020-05-13","scope":"insider"},{"id":3255836,"accession":"0001209191-20-018649","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-018649","line_url":"/filing/0001209191-20-018649#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3250.0,"shares_display":"3,250","price_per_share":14.87,"price_display":"14.87","price_state":"stated","total_value":48327.5,"total_display":"48,327.50","total_whole":"48,328","shares_owned_after":25646.0,"shares_owned_after_display":"25,646","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-10","filed_date":"2020-03-12","scope":"insider"},{"id":2074835,"accession":"0001209191-20-010482","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-010482","line_url":"/filing/0001209191-20-010482#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":16.55,"price_display":"16.55","price_state":"stated","total_value":20687.5,"total_display":"20,687.50","total_whole":"20,688","shares_owned_after":25646.0,"shares_owned_after_display":"25,646","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-18","filed_date":"2020-02-19","scope":"insider"},{"id":2074833,"accession":"0001209191-20-010482","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-010482","line_url":"/filing/0001209191-20-010482#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":16.72,"price_display":"16.72","price_state":"stated","total_value":20900.0,"total_display":"20,900.00","total_whole":"20,900","shares_owned_after":26896.0,"shares_owned_after_display":"26,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-14","filed_date":"2020-02-19","scope":"insider"},{"id":8066289,"accession":"0001209191-19-030659","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-030659","line_url":"/filing/0001209191-19-030659#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":812.0,"shares_display":"812","price_per_share":17.76,"price_display":"17.76","price_state":"stated","total_value":14421.12,"total_display":"14,421.12","total_whole":"14,421","shares_owned_after":18185.0,"shares_owned_after_display":"18,185","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-15","filed_date":"2019-05-16","scope":"insider"},{"id":8066285,"accession":"0001209191-19-030659","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-030659","line_url":"/filing/0001209191-19-030659#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":813.0,"shares_display":"813","price_per_share":17.78,"price_display":"17.78","price_state":"stated","total_value":14455.14,"total_display":"14,455.14","total_whole":"14,455","shares_owned_after":18997.0,"shares_owned_after_display":"18,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-14","filed_date":"2019-05-16","scope":"insider"},{"id":8232155,"accession":"0001209191-19-011822","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-011822","line_url":"/filing/0001209191-19-011822#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":21.52,"price_display":"21.52","price_state":"stated","total_value":26900.0,"total_display":"26,900.00","total_whole":"26,900","shares_owned_after":13810.0,"shares_owned_after_display":"13,810","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-19","filed_date":"2019-02-20","scope":"insider"},{"id":8232147,"accession":"0001209191-19-011822","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-011822","line_url":"/filing/0001209191-19-011822#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":21.44,"price_display":"21.44","price_state":"stated","total_value":26800.0,"total_display":"26,800.00","total_whole":"26,800","shares_owned_after":15060.0,"shares_owned_after_display":"15,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-15","filed_date":"2019-02-20","scope":"insider"},{"id":7920776,"accession":"0001209191-19-009926","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-009926","line_url":"/filing/0001209191-19-009926#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":992.0,"shares_display":"992","price_per_share":21.5,"price_display":"21.50","price_state":"stated","total_value":21328.0,"total_display":"21,328.00","total_whole":"21,328","shares_owned_after":16007.0,"shares_owned_after_display":"16,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-12","filed_date":"2019-02-13","scope":"insider"},{"id":7920772,"accession":"0001209191-19-009926","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-009926","line_url":"/filing/0001209191-19-009926#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":993.0,"shares_display":"993","price_per_share":21.38,"price_display":"21.38","price_state":"stated","total_value":21230.34,"total_display":"21,230.34","total_whole":"21,230","shares_owned_after":16999.0,"shares_owned_after_display":"16,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-11","filed_date":"2019-02-13","scope":"insider"},{"id":6869826,"accession":"0001209191-18-059065","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-059065","line_url":"/filing/0001209191-18-059065","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001698262","owner_name":"ROTE WILLIAM E.","owner_display_name":"ROTE WILLIAM E.","owner_url":"/insider/0001698262","role":"Officer (Senior Vice President, R&D)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":24.3201968,"price_display":"24.32","price_state":"stated","total_value":60800.492,"total_display":"60,800.49","total_whole":"60,800","shares_owned_after":18304.0,"shares_owned_after_display":"18,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-15","filed_date":"2018-11-16","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2018-11-15|6869821","ledger_fault":false,"count":{"value":53,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":53,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":53},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001438533","name":"Travere Therapeutics, Inc.","url":"/issuer/0001438533","role":"Officer (Chief Research Officer)","n_filings":37,"first_seen":"2018-02-16","last_seen":"2026-05-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001698262","retrieved_at":"2026-08-27T02:23:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}